MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM)

M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez (Madrid, Spain)

Meeting: 2023 International Congress

Abstract Number: 315

Keywords: Hemichorea, Parkinsonism, Single-photon emission computed tomography(SPECT)

Category: Parkinsonism, Others

Objective: To describe a case of secondary parkinsonism of unhabitual cause and complex treatment.

Background: Secondary parkinsonism constitutes approximately 15% of all parkinsonism cases in patients over 40 years old. In the literature, there have been reported few cases that CCM may be a cause of secondary parkinsonism.

We report a 72-years-old female patient with 11-years history of non-progressive right parkinsonism due to a CCM in the left substantia nigra (SN).

Method: In August 2012 patient had been complaining about resting tremor in the RUL for the past 3 years. The neurological examination revealed resting tremor in the right extremities with mild bradykinesia of the RLL. A brain SPECT with DaTscan revealed a decrease in presynaptic dopaminergic transporters in the left putamen. She was diagnosed of Parkinson’s disease and dopaminergic treatment was started with partial symptoms improvement. During the follow-up, a very slow symptoms progression was noticed in the right hemibody. In April 2021 she presented involuntary choro-ballistic movements of the right extremities of sudden onset. A Cranial CT revealed a left thalamo-capsular hematoma. There was favorable evolution with disappearance of involuntary movements. A Cranial MRI showed an old hematoma on the left subthalamic nucleus that seemed to be due to a CCM located in the left SN. Surgical treatment was ruled out due to the lesion location.

Results: In August 2022 she experienced another episode of involuntary movements in the right extremities. A CT revealed a new thalamo-mesencephalic hematoma. The involuntary movements persisted, so dopaminergic therapy was gradually withdrawn. There wasn’t reappearance of parkinsonian symptoms neither improvement in the hyperkinetic disorder. Treatment with risperidone was added with slight improvement. The CCM was successfully treated with radiotherapy. Another SPECT showed no changes compared to the previous one in 2012, so the final diagnosis of secondary parkinsonism of structural cause was established.

Conclusion: There are only four descriptions in the medical literature about secondary parkinsonism induced by CCM in basal ganglia. None of these cases have been clinically followed up for more than 10 years. This is the first report of parkinsonism due to CCM located in SN.

This is the second description in the literature about pathological DaTscan where we can find a secondary parkinsonism caused by CCM in the basal ganglia.

FIGURE 1

FIGURE 2

References: 1. R. Alp, S.I. Alp, H. Üre, Cavernous hemangioma: a rare cause for secondary parkinsonism: a case report, Int. J. Neurosci. 119 (2009) 2112–2117, https://doi.org/ 10.1080/00207450903139648.
2. S. Ertan, G. Benbir, T. Tanriverdi, I. Alver, M. Uzan, Parkinsonism caused by ca- vernoma located in basal ganglion, Parkinsonism Relat. Disord. 11 (2005) 517–519, https://doi.org/10.1016/j.parkreldis.2005.07.003.
3. S.-T. Li, J. Zhong, Surgery for mesencephalic cavernoma: case report, Surg. Neurol. 67 (2007) 413–417, https://doi.org/10.1016/j.surneu.2006.07.015.
4. R.C.S. Seet, E.C.H. Lim, Symptomatic segmental dystonia from a cavernous angioma in the centrum semiovale, Parkinsonism Relat. Disord. 11 (2005) 65–67, https:// doi.org/10.1016/j.parkreldis.2004.08.003.
5. Lang AE, Lozano AM: Parkinson’s disease. First of two parts. N Engl J Med. 1998, 339:1044-1053. 10.1056/NEJM199810083391506
6. Aydin S, Esen Aydin A, Yuksel O, et al. (March 26, 2021) Secondary Parkinsonism in a Patient With a Cerebral Cavernous Hemangioma Treated With Stereotactic Radiosurgery. Cureus 13(3): e14128. DOI 10.7759/cureus.14128
7. Modreanu RM, Buhmann C, Hauptmann B, Nine-years follow-up of cavernoma located in basal ganglia mimicking Parkinson’s Disease, Clinical Neurology and Neurosurgery 190 (2020) 105664, https://doi.org/10.1016/j.clineuro.2020.105664.
8. Höllerhage M, Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults, International Review of Neurobiology, Volume 149 ISSN 0074-7742, https://doi.org/10.1016/bs.irn.2019.10.010.

To cite this abstract in AMA style:

M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez. Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM) [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/hemiparkinsonism-secondary-to-a-cerebral-cavernous-malformation-ccm/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hemiparkinsonism-secondary-to-a-cerebral-cavernous-malformation-ccm/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley